CamKIId inhibitor therapeutic - Vasa Therapeutics
Alternative Names: Calcium calmodulin dependent protein kinase II delta therapy - Vasa Therapeutics; CamK2d inhibitor therapeutic - Vasa TherapeuticsLatest Information Update: 08 Mar 2024
At a glance
- Originator Vasa Therapeutics
- Class Antiarrhythmics; Heart failure therapies; Small molecules
- Mechanism of Action Calcium-calmodulin-dependent protein kinase type 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Arrhythmias; Heart failure
Most Recent Events
- 28 Feb 2024 Early research in Arrhythmias in USA (unspecified route)prior to February 2024 (Vasa Therapeutics pipeline, February 2024)
- 28 Feb 2024 Early research in Heart failure in USA (unspecified route) prior to February 2024 (Vasa Therapeutics pipeline, February 2024)